Today, biomarker testing may help deliver the right cancer treatment to the right patient.

That's the goal of bio-specific medicine. It is an important part of the future of cancer care. Bio-specific medicine is based on testing an individual tumor's unique molecular characteristics to help guide treatment options. Ideally, understanding the underlying differences in tumor biology of some cancers would help clinicians select treatment options that may have a high likelihood of benefit and a lower likelihood of toxicity.

Cancer: It's Personal is a program designed to educate and provide resources that healthcare practitioners may use to have more informed conversations with their patients about bio-specific medicine and biomarkers.

The Role Of BioMarkers

See the types of biomarkers and learn how these indicators are becoming a key part of cancer treatment.

Go

Screening for Biomarkers

Learn about three kinds of screening tools used to identify and categorize biomarkers.

Go

Who and When to Test

Read what to consider when determining whether a patient may be an appropriate candidate for biomarker testing.

Go

The information provided in this site is intended only for healthcare professionals in the United States.
Copyright © 2011 Pfizer Inc. All rights reserved.